Cytokinetics | CYTK - EPS Earnings Per Share


Cytokinetics reported $-1.37 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -1.37 -1.56 -2.55 Nov/04
FY2026Q2 Jun/2026 -1.50 -1.64 -1.12 Aug/06
FY2026Q1 Mar/2026 -1.67 -1.65 -1.36 May/05
FY2025Q4 Dec/2025 -1.50 -1.56 -1.26 Feb/24
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05




Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Arca Biopharma USD -0.58 0.04 Mar/2026
Bayer EUR 0.31 0.64 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cytokinetics USD -1.37 0.13 Sep/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Exelixis USD 0.94 0.03 Sep/2026
Geron USD -0.02 0.01 Jun/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Ligand Pharmaceuticals USD 2.67 0.3 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026